BR9812066A - Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação - Google Patents

Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação

Info

Publication number
BR9812066A
BR9812066A BR9812066-2A BR9812066A BR9812066A BR 9812066 A BR9812066 A BR 9812066A BR 9812066 A BR9812066 A BR 9812066A BR 9812066 A BR9812066 A BR 9812066A
Authority
BR
Brazil
Prior art keywords
treating
bacterial infection
farm animal
enteric
respiratory bacterial
Prior art date
Application number
BR9812066-2A
Other languages
English (en)
Inventor
Helmut Kropp
Daniel O Farrington
Jeffrey N Clark
Ronald W Ratcliffe
Robert D Wilkening
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BR9812066A publication Critical patent/BR9812066A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSO PARA TRATAMENTO OU PREVENçãO DE INFECçãO ENTéRICA OU RESPIRATóRIA BACTERIANA EM UM ANIMAL DE CRIAçãO". 8a-Azalídeos são úteis no tratamento e na prevenção de infecções entéricas e respiratóricas bacterianas em animais de criação, particularmente em gado bovino e suíno.
BR9812066-2A 1997-09-10 1998-09-04 Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação BR9812066A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5832997P 1997-09-10 1997-09-10
GBGB9806029.6A GB9806029D0 (en) 1998-03-20 1998-03-20 8a-Azalides as veterinary antimicrobial agents
PCT/US1998/018573 WO1999012542A1 (en) 1997-09-10 1998-09-04 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS

Publications (1)

Publication Number Publication Date
BR9812066A true BR9812066A (pt) 2000-09-26

Family

ID=10828979

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812066-2A BR9812066A (pt) 1997-09-10 1998-09-04 Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação

Country Status (22)

Country Link
EP (2) EP1011664B1 (pt)
CN (1) CN1152681C (pt)
AT (2) ATE535248T1 (pt)
AU (1) AU730172B2 (pt)
BR (1) BR9812066A (pt)
CA (1) CA2301872C (pt)
CZ (1) CZ289868B6 (pt)
DE (1) DE69827814T2 (pt)
DK (2) DK1011664T3 (pt)
EA (1) EA001530B1 (pt)
ES (2) ES2376432T3 (pt)
GB (1) GB9806029D0 (pt)
HU (1) HU228758B1 (pt)
IL (1) IL134762A (pt)
ME (1) ME00858B (pt)
NZ (1) NZ503145A (pt)
PL (1) PL192915B1 (pt)
PT (2) PT1011664E (pt)
RS (1) RS49837B (pt)
SI (2) SI1011664T1 (pt)
SK (1) SK284791B6 (pt)
WO (1) WO1999012542A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6353096B1 (en) 1999-04-01 2002-03-05 Merial Process of use in converting the 4″(S)-OH functional group of the cladinose unit of an azamacrolide to 4″(R)-NH2
FR2788524B1 (fr) * 1999-01-18 2002-04-26 Merial Sas Procede utile pour transformer la fonction 4"(s)-oh du motif cladinose d'un aza macrolide en 4"(r)-nh2
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な４’’アミノ結合マクロライド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281518A (en) * 1986-05-01 1994-01-25 Washington Research Foundation Detection of a unique chlamydia strain associated with acute respiratory disease
GB8726384D0 (en) * 1987-11-11 1987-12-16 Coopers Animal Health Veterinary treatment
US4956294A (en) * 1988-03-07 1990-09-11 Merck & Co., Inc. Culture of Streptoverticillium synroense for producing an antibacterial
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5202434A (en) * 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A

Also Published As

Publication number Publication date
ATE283055T1 (de) 2004-12-15
EP1510214A3 (en) 2005-03-23
PT1011664E (pt) 2005-02-28
AU730172B2 (en) 2001-03-01
PT1510214E (pt) 2012-02-06
PL192915B1 (pl) 2006-12-29
DK1510214T3 (da) 2012-03-19
CZ289868B6 (cs) 2002-04-17
GB9806029D0 (en) 1998-05-20
CN1278722A (zh) 2001-01-03
ATE535248T1 (de) 2011-12-15
CA2301872A1 (en) 1999-03-18
AU9566498A (en) 1999-03-29
YU14700A (sh) 2002-11-15
RS49837B (sr) 2008-08-07
SI1510214T1 (sl) 2012-04-30
EA200000305A1 (ru) 2000-08-28
WO1999012542A1 (en) 1999-03-18
ES2376432T3 (es) 2012-03-13
EP1011664A1 (en) 2000-06-28
IL134762A (en) 2005-08-31
SK284791B6 (sk) 2005-11-03
ME00858B (me) 2008-08-07
PL339140A1 (en) 2000-12-04
DK1011664T3 (da) 2005-02-14
SI1011664T1 (en) 2005-02-28
IL134762A0 (en) 2001-04-30
EP1510214B1 (en) 2011-11-30
HUP0003845A3 (en) 2003-05-28
DE69827814T2 (de) 2005-11-24
EP1011664B1 (en) 2004-11-24
CZ2000896A3 (cs) 2000-10-11
EP1510214A2 (en) 2005-03-02
CN1152681C (zh) 2004-06-09
EA001530B1 (ru) 2001-04-23
HU228758B1 (en) 2013-05-28
EP1011664A4 (en) 2001-05-16
HUP0003845A2 (hu) 2001-08-28
SK3222000A3 (en) 2001-01-18
NZ503145A (en) 2001-02-23
DE69827814D1 (de) 2004-12-30
CA2301872C (en) 2006-12-19
ES2232964T3 (es) 2005-06-01

Similar Documents

Publication Publication Date Title
BR9507502A (pt) Formulação de tablete processo de tratamento de infecções bacteriais em seres humanos ou em animais processo para preparação de uma formulação de tablete uso de uma formulação de tablete e processo de tratamento de uma infeção bacterial em um paciente humano
BR0007166A (pt) Método para aumentar a atividade dos animais de estimação
DE69731309D1 (de) Impfstofformel auf polynukleotidbasis zur behandlung von hundekrankheiten, insbesondere solcher des atmungs- und verdauungstraktes
AU7814498A (en) Multivalent (in ovo) avian vaccine
IL122248A0 (en) Use of nisin for treating an infection
BR9911094A (pt) Composições e métodos para o tratamento detosse
BR9812066A (pt) Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
CA2288341A1 (en) Erythropoietin in the treatment of domestic and livestock animals for anemia
BR9710532A (pt) Composi-Æo pesticida processo para o tratamento antiparas¡tico palheiro de animais palheiro de aves e assoalho ou esterco l¡quido
DE69827163D1 (de) Phytase zur vorbeugung oder behandlung von mastitis
GB2377638B (en) Treatment of infection in animals
DE69421253T2 (de) Feste insectizide Formulierung
BR9712633A (pt) Método para o tratamento de infecção por streptococcus pneumoniae
EP1779853A3 (en) 9a-azalides as veterinary antimicrobial agents
CY1112647T1 (el) 8α-αζαλιδες ως κτηνιατρικα αντιμικροβιακα μεσα
ITFI910190A0 (it) Impianto di trattamento dei liquami animali, specialmente degli allevamenti di suini e bovini
ITPD940196A0 (it) Attrezzatura particolarmente per la regolazione degli unghioni in bovini o altri animali da allevamento.
BR9301001A (pt) Processo para tratamento de carcaças de animais para controlar o crescimento bacteriano
ZA9811443B (en) A method of treating and sterilizing poultry and animal manures and litter.
UA37648A (uk) Спосіб лікування респіраторних захворювань у телят

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NOS ARTS. 8O, 11, 13 E 25 DA LPI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

Free format text: NOME ALTERADO DE: MERCK AND CO., INC.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]